BRCA2 Variants and cardiovascular disease in a multi-ethnic study
Journal Articles
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
AbstractBackgroundGermline mutations ofBRCA1/2are associated with hereditary breast and ovarian cancer. Recent data suggests excess mortality in mutation carriers beyond that conferred by neoplasia, and recentin vivoandin vitrostudies suggest a modulatory role for BRCA proteins in endothelial and cardiomyocyte function. We therefore tested the association ofBRCA2variants with clinical cardiovascular disease (CVD).MethodsUsing data from 1,170 individuals included in two multi-ethnic population-based studies (SHARE and SHARE-AP), the association betweenBRCA2variants and CVD was evaluated. 15 SNPs inBRCA2with minor allele frequencies(MAF) > 0.01had been previously genotyped using the cardiovascular gene-centric 50 k SNP array. 115 individuals (9.8%) reported a CVD event, defined as myocardial infarction (MI), angina, silent MI, stroke, and angioplasty or coronary artery bypass surgery. Analyses were adjusted for age and sex. The SNPs rs11571836 and rs1799943 were subsequently genotyped using the MassARRAY platform in 1,045 cases of incident MI and 1,135 controls from the South Asian subset of an international case-control study of acute MI (INTERHEART), and rs11571836 was imputed in 4,686 cases and 4500 controls from the Pakistan Risk of Myocardial Infarction Study (PROMIS).ResultsTwoBRCA2SNPs, rs11571836 and rs1799943, both located in untranslated regions, were associated with lower risk of CVD (OR 0.47 p = 0.01 and OR 0.56 p = 0.03 respectively) in the SHARE studies. Analysis by specific ethnicities demonstrated an association with CVD for both SNPs in Aboriginal People, and for rs11571836 only in South Asians. No association was observed in the European and Chinese subgroups. A non-significant trend towards an association between rs11571836 and lower risk of MI was observed in South Asians from INTERHEART [OR = 0.87 (95% CI: 0.75-1.01) p = 0.068], but was not evident in PROMIS [OR = 0.96 (95% CI: 0.90-1.03) p = 0.230]. Meta-analysis of both case-control studies resulted in a combined OR of 0.94 (95% CI: 0.89-1.004, p = 0.06).ConclusionsAlthough there was an association between two SNPs inBRCA2and CVD in a multi-ethnic population, these results were not replicated in two South Asian case-control studies of incident MI. Future studies exploring the association betweenBRCAvariants and cardiovascular disorders are needed to clarify the role, if any, forBRCAvariants in CVD pathogenesis.
